O

OCTIMET Oncology NV

4 employees

OCTIMET has licensed from Janssen Pharmaceutica, highly selective MET kinase inhibitors with clean safety profiles

Basic info

Industry

research services

Sectors

Biotechnology
Medical

Date founded

2016

Funding rounds raised

Total raised

$12M

from 3 investors over 3 rounds

O

OCTIMET Oncology NV raised $12M on January 19, 2017

Investors: Omnes, FundPlus and V-Bio Ventures

FAQ